Howe Jill Ann 4
4 · Lineage Cell Therapeutics, Inc. · Filed Mar 10, 2023
Insider Transaction Report
Form 4
Howe Jill Ann
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2023-03-09+150,000→ 150,000 totalExercise: $1.46Exp: 2033-03-09→ Common Shares (150,000 underlying)
Footnotes (1)
- [F1]One quarter of the options shall vest on March 9, 2024, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.